Anisotropic compounds of the formula (1) specified in claim 1 are suitable, owing to their low Δε/ε⊥ values for liquid crystal displays which have high information densities of for examples up to 106 image dots and accordingly need to be highly multiplexible; compared with known compounds they offer improved application properties and are relatively simple to synthesize.

Patent
   RE36849
Priority
Apr 16 1984
Filed
Apr 01 1993
Issued
Sep 05 2000
Expiry
Sep 05 2017
Assg.orig
Entity
Large
0
69
EXPIRED
17. A compound of the formula (8) ##STR18## wherein R is an alkyl, alkoxy, alkenyl or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain,
X2 and X3 are independently hydrogen, halogen or nitrile, and
Halogen is fluorine or chlorine,
with the proviso that at least one of the groups X2 and X3 is not hydrogen.
1. A compound of the formula ##STR15## in which R is an alkyl, alkoxy, or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain, X2 and X3 are independently hydrogen, halogen or nitrile, X4 is halogen or nitrile, Z is the ether oxygen bridge --O-- and m and n are independently 0, 1 or 2 with the provisos that
(a) the sum of n and m is at least 1 and at most 3, and
(b) at least one of the groups X2 and X3 is not hydrogen.
2. A compound according to claim 1, wherein R is an alkyl group having 1-12 C atoms.
3. A compound according to claim 1 or 2, wherein halogen is fluorine or chlorine.
4. A compound according to claim 1, wherein one of X2, X3 is a halogen atom and the other is hydrogen.
5. A compound according to claim 1, of the formula ##STR16## in which R, X2, X3 and X4 have the meaning specified in claim 1 and m1 if 0 or 1.
6. A compound according to claim 5, wherein R is an alkyl group having 1-12 C atoms.
7. A compound according to claim 5 or 6, wherein X4 is a nitrile group and one of X2, X3 is a halogen atom and the other is hydrogen.
8. A compound according to claim 5 or 6, wherein X2 is fluorine.
9. A compound according to claim 6 or 7, wherein X3 is fluorine or chlorine.
10. A compound according to claim 1, of the formula ##STR17## in which R, X2, and X3 and X4 have the meaning specified in claim 1.
11. A compound according to claim 10, wherein R is an alkyl group having 1-12 C atoms.
12. A compound according to claim 10 or 11, wherein X4 is a nitrile group and one of X2, X3 is a halogen atom and the other is hydrogen.
13. A compound according to claim 10 or 11 wherein X2 is fluorine.
14. A compound according to claim 10 or 11 wherein X3 is fluorine or chlorine.
15. In a liquid crystal mixture having at least two liquid crystal components; the improvement wherein at least one such component is a compound of claim 1.
16. In an electro-optical display element with multiplex operation comprising a liquid crystal mixture as dielectric, the improvement wherein the mixture is one of claim 15.
18. A compound of claim 17, wherein R is alkyl of 1-12 C atoms.19. A compound of claim 17, wherein X2 and X3 are H, F or Cl.20. A compound of claim 17, wherein one of X2 and X3 is F and the other is H.21. A compound of claim 17, wherein X2 is H, X3 is F and Halogen is F.22. A compound of claim 20, wherein halogen is Cl.23. A compound of claim 17 which is
2-(4-trans-4-propyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-4-pentyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-4-heptyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-4-propyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-4-pentyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-4-heptyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(trans-4-methyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-ethyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-propyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-butyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-pentyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-hexyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-heptyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(trans-4-methyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(trans-4-ethyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(trans-4-propyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(trans-4-butyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(trans-4-pentyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(trans-4-hexyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane, or
2-(trans-4-heptyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane..I add.24. A compound of formula (9) ##STR19## wherein R is an alkyl, alkoxy, alkenyl or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain,
X2 and X3 are independently hydrogen, halogen or nitrile, and
Halogen is fluorine or chlorine,
with the proviso that at least one of the groups X2 and X3 is not hydrogen.25. A compound of claim 24, wherein R is alkyl of
1-12 C atoms.26. A compound of claim 24, wherein X2 and X3 are H, F or Cl.27. A compound of claim 24, wherein one of X2 and X3 is F and the other is H.28. A compound of claim 24, wherein X2 is H, X3 is F and Halogen is F.29. A compound of claim 27, wherein halogen is Cl.30. A compound of claim 24, which is
2-(4-trans-methylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-ethylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-propylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-butylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-pentylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-hexylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-heptylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-octylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane
2-(4-trans-methylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-ethylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-propylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-butylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-pentylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-hexylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-heptylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-octylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane
2-(4-trans-methylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-ethylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-propylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-butylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-pentylcyclohexyl)-1-(2,4-diflurophenyl)ethane
2-(4-trans-hexylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-heptylcyclohexyl)-1-(2,4-difluorophenyl)ethane
2-(4-trans-methylcyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(4-trans-ethylcyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(4-trans-propylcyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(4-trans-butylcyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(4-trans-pentylcyclohexyl)-1-(3,4-difluorophenyl)ethane
2-(4-trans-hexylcyclohexyl)-1-(3,4-difluorophenyl)ethane, or
2-(4-trans-heptylcyclohexyl)-1-(3,4-difluorophenyl)ethane.31 . A compound of formula (2) ##STR20## wherein R is an alkyl, alkoxy, alkenyl or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain,
X2 and X3 are independently hydrogen, halogen or nitrile, and
Halogen is fluorine or chlorine,
with the proviso that at least one of the groups X2 and X3 is not hydrogen.32. A compound of claim 31, wherein X2 and X3 are H, F or Cl.33. A compound of claim 31, wherein one of X2 and X3 is F and the other is H.34. A compound of claim 31, which is
2-(4-[trans-4-heptylcyclohexyl]phenyl)-1-(4-chloro-2-fluorophenyl)ethane, or
2-(4-[trans-4-pentylcyclohexyl]phenyl)-1-(4-chloro-2-fluorophenyl)ethane..I addend.35. In a liquid crystal mixture having at least two liquid crystal components, the improvement wherein at least one such component is a compound of claim 17.36. In a liquid crystal mixture having at least two liquid crystal components, the improvement wherein at least one such component is a compound of claim 24.37. In a liquid crystal mixture having at least two liquid crystal components, the improvement wherein at least one such component is a compound of claim 31.38. A compound of claim 31, wherein R is alkyl of 1-11 C atoms.39. A compound of claim 31, wherein R is alkoxy or
alkanoyloxy of 1-12 C atoms.40. A compound of claim 31, wherein R is alkoxy, alkenyl or alkanoyloxy of 1-12 C atoms.41. A compound of claim 31, wherein halogen is fluorine.42. A compound of claim 31, wherein halogen is chlorine.43. A compound of claim 17, wherein R is alkyl of 1-11 C atoms.44. A compound of claim 17, wherein R is alkoxy or alkanoyloxy of 1-12 C atoms.45. A compound of claim 17, wherein R is alkoxy, alkenyl or alkanoyloxy of 1-12 C atoms.46. A compound of claim 17, wherein R is alkyl, alkoxy or alkanoyloxy which has 1-12 C atoms in each case in the alkyl moiety.47. A compound of claim 24, wherein R is alkyl, alkoxy or alkanoyloxy which has 1-12 C atoms in each case in the alkyl moiety.48. A compound of claim 31, wherein R is alkyl, alkoxy or alkanoyloxy which has 1-12 C atoms in each case in the alkyl moiety.49. A compound of claim 17, wherein R is alkenyl which has 1-12 C atoms in each case in the alkyl moiety.50. A compound of claim 24, wherein R is alkenyl which has 1-12 C atoms in each case in the alkyl moiety.51. A compound of claim 31, wherein R is alkenyl which has 1-12 C atoms in each case in the alkyl
moiety.52. A compound of claim 21, wherein R is alkyl.53. A compound of claim 52 which is
2-(trans-4-methyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-ethyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-propyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-butyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-pentyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-hexyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-heptyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(trans-4-methyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(trans-4-ethyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(trans-4-propyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(trans-4-butyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(trans-4-pentyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(trans-4-hexyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane, or
2-(trans-4-heptyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)-ethane.. Iadd.54. A compound of claim 28, wherein R is alkyl.55. A compound of claim 54 which is
2-(4-trans-methylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-ethylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-propylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-butylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-pentylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-hexylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-heptylcyclohexyl)-1-(2,4-difluorophenyl)-ethane
2-(4-trans-methylcyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(4-trans-ethylcyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(4-trans-propylcyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(4-trans-butylcyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(4-trans-pentylcyclohexyl)-1-(3,4-difluorophenyl)-ethane
2-(4-trans-hexylcyclohexyl)-1-(3,4-difluorophenyl)-ethane, or
2-(4-trans-heptylcyclohexyl)-1-(3,4-difluorophenyl)-ethane.5 6. A compound according to claim 7, wherein X3 is fluorine or chlorine.

This application is a continuation of application Ser. No. 07/444,251, filed Dec. 1, 1989 now abandoned, which in turn is a reissue of application Ser. No. 06/815,708, filed Dec. 16, 1985 (U.S. Pat. No. 4,710,315).

In electrooptical displays based on liquid crystals, which are also referred to as liquid crystal displays or LCDs, the liquid crystal phase is present as a dielectric between two sheetlike electrodes which are spaced from each other and are constructed in patterns or grids; selective excitation of predetermined electrode field regions has the effect of changing the position or orientation of the molecules of the dielectric within the regions of the selective excitation and thereby of bringing about a visible selective local modification of the dielectric.

This effect requires potentials whose size is dependent inter alia on the degree of anisotropy of the liquid crystal phase; this degree of anisotropy is expressed in general for a given liquid crystal substance by the difference (Δ) of the dielectric constants (ε) parallel to the electric field (ε∥) minus that perpendicular thereto (ε⊥), i.e. by the relationship referred to in short as dielectric constant anisotropy or DCA Δε=ε∥-ε⊥.

In liquid crystal displays which are based on the principle of the twisted nematic cell (TN=twisted nematic; see W. Helfrich, and M. Schadt, Appl. Phys. Lett. 18 (1971) 127), a property which is dependent upon the DCA is the so-called threshold voltage, which in turn must not be excessively high for various reasons, such as CMOS compatibility, and which in practice can be the smaller, the higher the value of Δε is.

Since Δε is the difference of two values, the same difference can be the result of very different pairs of values, for example the resulting DCA being the same for

Δε=21(ε∥)-20(ε⊥)=1

Δε=2(ε∥)-1(ε⊥)=1.

For a completely different reason, namely because of the matrix addressing, which is essential in particular for displays having high information content (for example within the range of up to 106 image dots per display), and the attendant desirability of a very steep and high shoulder of discontinuity in the voltage/contrast diagram of the liquid crystal dielectric of the liquid crystal display, the value of the ratio Δε/ε⊥ should in addition be small; from the above numerical example it will be readily understood that this ideal can be approached in two ways, namely:

(a) by using appropriate liquid crystal mixtures of substances having a strongly positive or weakly negative DCA (see for example A. R. Kmetz, SID Digest, Tech. Papers IX (1078) 70); this has in particular the disadvantage that the mixtures tend to form smectic phases;

(b) by using substances which, in the molecule, have a marked polarization not only in the longitudinal direction but also in the transverse direction, relative to the generally "stretched" form of the liquid crystal molecules (M. A. Osman, European Patent Application Publication No. 0,019,665); this has the advantage that the ratio Δε/ε⊥ can be reduced by increasing the contribution and not or not necessarily by reducing the ε∥ contribution of the same molecule. The disadvantages of the compounds described in the citeed European patent application reside in their relatively high viscosity or relatively high melting points and in the usually difficult synthesis and/or low stability.

It is an object of the invention to specify a new class of anisotropic compounds which are suitable for liquid crystal displays or for liquid crystal mixtures and permit a substantially free choice of the Δε and ε contributions by reducing or eliminating the disadvantages of the known compounds.

This object is achieved according to the invention with anisotropic compounds of the formula (1) ##STR1## in which R is an alkyl, alkoxy, oxaalkyl, alkenyl or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain, X2 and X3 are selected from hydrogen, halogen and nitrile, X4 is halogen or nitrile, Z is the methylene group --CH2 -- or the ether oxygen bridge --O-- and m and n are each 0, 1 or 2 with the provisos that

(a) the sum of n and m is at least 1 and at most 3,

(b) m is 2 and n 0 if Z is --CH2 -- and X4 nitrile,

(c) at least one of the groups X2 and X3 is not hydrogen and

(d) n is 0 or 1 if Z is --CH2 -- and X4 halogen.

R is preferably an alkyl, alkoxy or alkanoyloxy group which has in each case 1-12 C atoms in the alkyl moiety and which has a straight or branched and chiral or non-chiral chain, i.e. C1 -C12 -alkyl, C1 -C12 -alkoxy and ##STR2## groups, such as, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl or dodecyl as alkyl moiety including the corresponding chiral-isomeric alkyl moieties such as, for example, 1-methylpropyl, 1-methylbutyl, 2-methylbutyl, 1-methylpentyl, 2-methylpentyl, 3-methylpentyl, 1- or 2- or 3- or 4-methylhexyl, 1- or 2- or 3- or 4- or 5-methylheptyl and further alkyl-alkyl groups formed on that basis and having an asymmetrical C atom. Alkyl moieties having 2-8 C atoms, in particular 3-8 C atoms, are frequently preferable.

In the formula (I), X2 and X3 are selected from hydrogen, halogen, fluorine, chlorine, bromine, iodine and nitrile (--C═N) with the proviso that at least one of the groups X2 and X3 is not hydrogen; Z is the methylene group --CH2 -- or the ether oxygen bridge --O--; m and n are each 0, 1 or 2 with the proviso that the sum of n and m is at least 1 and at most 3. For many purposes preference is given to compounds (1) in which n is 1 or 2, preferably 1, and m is 0 or 1. Z is preferably the ether oxygen bridge --O--.

Preferably one of the groups X2 and X3 is fluorine and the other hydrogen.

X4 is halogen or nitrile, preferably nitrile, fluorine or chlorine. If (m+n) is 2 or 3 and n is 1 or 2 and Z is --CH2 --, X is preferably F or Cl, particularly preferably F. If (m+n) is 1 and Z is --CH2 --, X4 is preferably F or Cl, particularly preferably F.

A preferred group of compounds (1) thus has the formula (9) ##STR3## in which R, X2 and X3 have the abovementioned meaning and Halogen is fluorine or chlorine, preferably fluorine.

A preferred group of compounds (1) has the formula (2) ##STR4## in which R, X2 and X3 have the abovementioned meaning and Halogen is preferably fluorine or chlorine, in particularly fluorine.

In a similarly preferred group of compounds of the formula (1) or (2), R is an alkyl group having 1-12 C atoms, preferably having 3-9 C atoms, such as, for example, n-pentyl or n-heptyl.

For many purposes, preference is further given to compounds (1) of the invention which have a longitudinally polarizing wing group, i.e. those in which X4 is the nitrile group (--C.tbd.N) or a halogen atom, in particular F, one of X2, X3 being a halogen atoms, in particular fluorine, and the other of X2, X3 being the hydrogen atom.

A further generally preferred group of compounds (1) are those of the formula (6) ##STR5## in which R, X2, X3 and X4 have the general preferred meaning specified for the formula (1) and m1 is 0 or 1.

A further generally preferred group of compounds (1) are those of the formula (7) ##STR6## in which R, X2, X3 and X4 have the meaning specified in claim 1 and X4 is preferably CN, F or Cl, in particular preferably CN. A further generally preferred group of compounds (1) are those of the formula (8) ##STR7## in which R, X2 and X3 have the meaning specified in claim 1.

R, X2 and X3 have the formulae (7) and (8) the general or preferred meaning specified for the formula (1).

The provision of compounds of the formula (1) also very generally represents an immense widening of the range of liquid crystal substances which, from various application aspects, are suitable for preparing nematic mixtures.

The compounds of the formula (1) have a wide range of uses. Depending on the choice of substituents, these compounds can be used as base materials of which liquid crystal dielectrics are predominantly composed; however, it is also possible to add to compounds of the formula (1) liquid crystal base materials from other classes of compound, for example in order to reduce the dielectric and/or optical anisotropy of such a dielectric. The compounds of formula (1) are also suitable as intermediates for preparing other substances which can be used as components of liquid crystal dielectrics.

The compounds of the formula (1) are in the pure state colourless and form liquid crystal mesophases within a temperature range which is favourably located for electro-optical use. They are very stable chemically, thermally and to light.

The invention thus relates to the compounds of the formula (1) and to the use of the compounds of the formula (1) as components of liquid crystal phases. The invention further relates to liquid crystal mixtures containing at least one compound of the formula (1) and liquid crystal display elements, in particular those with multiplex operation, which contain such mixtures.

Compounds of the formula (1) which have a branched wing group R can occasionally be of importance owing to superior solubility in the customary liquid crystal base materials, but in particular as chiral dopants, provided they are optically active. Branched groups of this kind generally contain not more than one chain branching. Preferred branched radicals R are isopropyl, 2-butyl (═1-methypropyl), isobutyl (2-methylpropyl), 2-methylbutyl, isopentyl (═3-methylbutyl), 2-methylpentyl, 3-methylpentyl, 2-ethylhexyl, 2-propylpentyl, 2-octyl, isopropoxy, 2-methylpropoxy, 2-methylbutoxy, 3-methylbutoxy, 2-methylpentoxy, 3-methylpentoxy, 2-ethylhexoxy, 1-methylhexoxy, 2-octyloxy, 2-oxa-3-methylbutyl and 3-oxa-4-methylpentyl. Such compounds can be used as components of smectic mixtures having ferroelectric properties.

Of the compounds of the formula (1), preference is given to those in which at least one of the radicals contained therein has one of the specified preferred meanings.

The compounds of the formula (1) are prepared by conventional methods, as described in the literature (for example in the standard works such as Houben-Weyl, Methoden der Organischen Chemie [Methods of Organic Chemistry], Georg Thieme-Verlag, Stuttgart), and in fact under reaction conditions which are known and suitable for the stated reactions using, if so desired, conventional variants which are not described here in detail.

The skilled person, through routine methods, can find appropriate methods of synthesis in the state of the art (for example German Offenlegungsschriften Nos. 2,344,732, 2,450,088, 2,429,093, 2,502,904, 2,636,684, 2,701,591 and 2,752,975 concerning compounds having 1,4-cyclohexylene and 1,4-phenylene groups; German Offenlegungsschrift No. 3,208,089, German Offenlegungsschrift No. 3,117,152, German Offenlegungsschrift No. 3,042,391 and European Offenlegungsschrift No. 84,194 concerning laterally substituted compounds; and German Offenlegungsschrift No. 3,201,721 concerning compounds having --CH2 CH2 -- bridge members).

The starting materials can, if desired, also be formed in situ by not isolating them out of the reaction mixture but immediately reacting them further to give the compounds of the formula (1).

For instance, those compounds of the formula (1) in which Z is the methylene bridge (--CH2 --) can preferably be prepared for example in accordance with scheme I below using a Grignard reaction and subsequent reduction, while those compounds of the formula (1) in which Z is the ether oxygen bridge (--O--) are advantageously accessible by condensation as per scheme II. Compounds of the formula (1) in which X2, X3 or X4 is the nitrile group can be obtained by nitrilation from the corresponding compounds (1) in which the corresponding X2, X3 or X4 is a halogen atom suitable for nitrilation, for example bromine.

Schemes I and II are subject to the further definitions:

A is the radical ##STR8## and B is the radical ##STR9## in which R, n, m, X2, X3 and X4 have the abovementioned meaning. ##STR10##

Suitable compounds of the formulae (I-1) and (I-2) and of the formulae (II-1) and (II-2) are either known or are obtainable analogously to the known compounds by standard methods.

An example of preparing a compound of the formula (I-2) is illustrated in scheme III below. ##STR11##

Liquid crystal mixtures (phases) according to the invention consist of 2 to 25, preferably 3 to 15, compoonents, including at least one compound of the formula (1). The other constituents are preferably selected from the nematic or nematogenic substances, in particular the known substances, from the classes of the azoxybenzenes, benzylideneanilines, biphenyls, terphenyls, phenyl or cyclohexyl benzoates, phenyl or cyclohexyl cyclohexanecarboxylate, phenylcyclohexanes, cyclohexylbiphenyls, cyclohexylcyclohexanes, cyclohexylnaphthalenes, 1,4-biscyclohexylbenzenes, 4,4'-biscyclohexylbiphenyls, phenyl- or cyclohexyl-pyrimidines, phenyl- or cyclohexyl-dioxanes, phenyl- or cyclohexyl-1,3-dithianes, 1,2-diphenylethanes, 1,2-dicyclohexylethanes, 1-cyclohexyl-2-phenylethanes, halogenated and non-halogenated stilbenes, benzyl phenyl ether, tolanes and substituted cinnamic acids.

The most important compounds which come into consideration as constituents of such liquid crystal phases can be characterized by the formula II

R'--L--G--E--R" II

in which L and E are each a carocyclic or heterocyclic ring system from the group comprising 1,4-disubstituted benzene and cyclohexane rings, 4'4-disubstituted biphenyl, phenylcyclohexane and cyclohexylcyclohexane systems, 2,5-disubstituted pyrimidine and 1,3-dioxane rings, 2,6-disubstituted naphthalene di- and tetrahydronaphthalene, quinazoline and tetrahydroquinazoline,

______________________________________
--CH═CH-- --N(O)═N--
--CH═CY-- --CH═N(O)--
--CH.tbd.C-- --CH2 --CH2 --
--CO--O-- --CH2 --O--
--CO--S-- --CH2 --S--
--CH═N-- --COO--Phe--COO--
______________________________________

or a C--C single bond, Y is halogen, preferably chlorine or --CN, and R' and R" are alkyl, alkoxy, alkanoyloxy or alkoxycarbonyloxy having up to 18, preferably up to 8, carbon atoms, or one of these radicals can also be CN, NC, NO2, CF3, F, Cl or Br.

In most of these compounds, R' and R" are different from each other, one of these radicals usually being an alkyl or alkoxy group. But it is also possible to use other variants of the proposed substituents. Many such substances or mixtures thereof are commercially available. All these substances can be prepared by methods described in the literature.

The phases according to the invention contain about 0.1 to 100, preferably 10 to 100%, of one or more compounds of the formula I.

Preference is also given to dielectrics according to the invention which contain 0.1 to 40, preferably 0.5 to 30%, of one or more compounds of the formula I.

The dielectrics according to the invention are prepared in conventional manner. As a rule, the components are dissolved in one another, advantageously at elevated temperature.

By means of suitable additives it is possible to modify the liquid crystal dielectrics according to the invention in such a way that they can be used in any previously disclosed type of liquid display element.

Such additives are known to the skilled person and are described in the literature in detail. For example it is possible to add conducting salts, preferably ethyldimethyldodecylammonium 4-hexyloxybenzoate, tetrabutylammonium tetraphenylboronate or complex salts of crown ethers (cf. for example I. Haller et al., Mol. Cryst. Liq. Cryst. volume 24, pages 249-258 (1973)) for improving the conductivity, dichroic dyes for preparing coloured guest-host systems or substances for modifying the dielectric anisotropy, the viscosity and/or the orientation of the nematic phases. Such substances are described for example in German Offenlegungsschriften Nos. 2,209,127, 2,240,864, 2,321,632, 2,338,281, 2,450,088, 2,637,430, 2,853,728 and 2,902,177.

The following examples will illustrate the invention without limiting it. m.p.=melting point, c.p.=clear point. Heretofore and hereinafter percentages are by weight; all temperatures are in degrees Celsius. "Conventional working up" means: addition of water, extraction with methylene chloride, separation, drying of the organic phase, evaporation and clarification of the product by distillation, crystallization and/or chromatography.

PAC Preparation of 4-(trans-4-pentylcyclohexylmethoxy)-3-fluorobenzonitrile; formula 6: R=n-pentyl, m1 =O, X2 =F, X4 =CN

This compound was prepared in accordance with scheme IV below. To this end, butan-2-one (50 ml) was added to 4-hydroxy-3-fluorobenzonitrile (1.0 g, 0.0074 mole) and trans-4-pentylcyclohexylmethyl bromide (2.5 g, 0.0102 mole); the mixture was heated to the reflux temperature, was maintained at the reflux temperature for 48 hours with stirring, was then cooled down to room temperature and was poured into water (250 ml), and the mixture was extracted with chloroform (three times 50 ml). The combined organic phases were washed with water and dried over magnesium sulfate. The crude product obtained after the chloroform had been evaporated off was purified by column chromatography over silica gel using toluene as the eluent. After the toluene had been evaporated off, the product was repeatedly recrystallized from methanol until the phase transition temperatures (in degrees Celsius, K=crystalline; N=nematic,; I=isotropic) were constant; the corresponding values were: K.57.5.N(45.5).I.

The trans-4-pentylcyclohexylmethyl bromide used was obtained by the method described in European Patent Application No. 80201158.5 from the corresponding carboxylic acid by reduction to give the corresponding methanol derivative and bromination of the latter.

The 4-hydroxy-3-fluorobenzonitrile was prepared as follows:

4-Bromo-2-fluoroanisole was obtained in almost quantitative yield by the method described by Gray, G. W., and Jones, B. (J. Chem. Soc. (1954), (1967)) and was heated in an amount of 93 g (0.4537 mole) with anhydrous copper (I) cyanide (49 g, 0.0544 mole) in dry dimethylformamide (90 ml) under reflux for 3.5 hours by the method described by Adamska, G. et al. (Mol. Cryst. Liqu. Cryst. 76 (1981) 93). The crude product thus obtained gave 39 g (57% yield) of pure 4-methoxy-3-fluorobenzonitrile, m.p. 98.5° to 99°C

5.0 g (0.0329 mole) of the compound thus obtained and 8.75 g (0.0658 mole) of anhydrous aluminium chloride were used together with 1.9 g (0.0329 mole) of sodium chloride to prepare a finely pulverulent mixture which was heated under anhydrous conditions at 210°C on an oil bath for 40 min. After cooling down, the mixture was treated with 250 ml of water and was extracted three times with 50 ml of diethyl ether each time. The combined ether extracts were extracted with sodium chloride solution (2×250 ml) and dried over magnesium sulfate. The solvent was evaporated under slightly reduced pressure, and the residue was crystallized from 1:1 toluene:hexane. This gave 3.0 g (66% yield) of pure 4-hydroxy-3-fluorobenzonitrile, m.p. 133.5° to 134.5°C ##STR12##

Analogously to scheme IV 4-hydroxy-2-fluorobenzonitrile can be used to produce the corresponding isomeric compounds according to the invention.

The method described in Example 1 was used to prepare compounds according to the invention of the formulae (20), (30), (40) and (50) indicated hereinafter and of the similarly indicated phase transition temperatures: ##STR13##

The method depicted in scheme V below was used to prepare the compounds according to the invention.

2-(4-[trans-4-heptylcyclohexyl]phenyl)-1-(4-chloro-2-fluorophenyl)ethane (K.58.5.N.83.I)

and

2-(4-[trans-4-pentylcyclohexyl]phenyl)-1-(4-chloro-2-fluorophenyl)ethane. ##STR14##

Further examples of compounds according to the invention of the formula (1) are as follows:

2-(4-trans-methylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-ethylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-propylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-butylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-pentylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-hexylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-heptylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-octylcyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-methylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-ethylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-propylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-butylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-pentylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-hexylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-heptylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-octylcyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-methylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-ethylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-propyllcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-butylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-pentylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-hexylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-heptylcyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(4-trans-methylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-ethylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-propylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-butylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-pentylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-hexylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-heptylcyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4-trans-4-propyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-4-pentyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-4-heptyl-4'-bicyclohexyl)-1-(4-chloro-2-fluorophenyl)ethane

2-(4-trans-4-propyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-4-pentyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(4-trans-4-heptyl-4'-bicyclohexyl)-1-(4-chloro-3-fluorophenyl)ethane

2-(trans-4-methyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-ethyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-propyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-butyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-pentyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-hexyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-heptyl-4'-bicyclohexyl)-1-(2,4-difluorophenyl)ethane

2-(trans-4-methyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-ethyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-propyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-butyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-pentyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-hexyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(trans-4-heptyl-4'-bicyclohexyl)-1-(3,4-difluorophenyl)ethane

2-(4'-methylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-ethylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-propylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-butylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-pentylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-hexylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-heptylbiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-methoxybiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-ethoxybiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-proproxybiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-butoxybiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

2-(4'-pentoxybiphenyl-4-yl)-1-(4-cyano-3-fluorophenyl)ethane

4-(trans-4-propylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4butylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-pentylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-ethylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-hexylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-octylcyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-methylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-ethylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-propylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-butylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-pentylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-hexylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-heptylcyclohexylmethoxy)-3-chlorobenzonitrile

4-(trans-4-propylcyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-butylcyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-pentylcyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-hexylcyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-heptylcyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-octylcyclohexylmethoxy)-2-fluorobenzonitrile

4-cyano-2-fluorophenyl 4-(trans-4-propylcyclohexyl)benzyl ether

4-cyano-2-fluorophenyl 4-(trans-4-pentylcyclohexyl)benzyl ether

4-cyano-3-fluorophenyl 4-(trans-4-propylcyclohexyl)benzyl ether

4-cyano-3-fluorophenyl 4-(trans-4-pentylcyclohexyl)benzyl ether

4-cyano-3-fluorophenyl 4-(trans-4-heptylcyclohexyl)benzyl ether

4-(trans-4-propyl-4'-bicyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-pentyl-4'-bicyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-heptyl-4'-bicyclohexylmethoxy)-3-fluorobenzonitrile

4-(trans-4-propyl-4'-bicyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-pentyl-4'-bicyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-heptyl-4'-bicyclohexylmethoxy)-2-fluorobenzonitrile

4-(trans-4-propyl-4'-bicyclohexylmethoxy)-1,2-benzodicarbonitrile

4-(trans-4-pentyl-4'-bicyclohexylmethoxy)-1,2-benzodicarbonitrile

4-(trans-4-heptyl-4'-bicyclohexylmethoxy)-1,2-benzodicarbonitrile

4-(trans-4-propyl-4'-bicyclohexylmethoxy)-1,3-benzodicarbonitrile

4-(trans-4-pentyl-4'-bicyclohexylmethoxy)-1,3-benzodicarbonitrile

4-(trans-4-heptyl-4'-bicyclohexylmethoxy-1,3-benzodicarbonitrile

Liquid crystal mixtures according to the invention contain at least one compound of the formula (1), usually together with known liquid crystal substances and additives which are known for the operation of electro-optical display cells of the various types. Preferably such mixtures contain two or more different compounds of the formula (1), for example in total in amounts of 1-90 mole %; such mixtures can be obtained in conventional manner by combining the components, if appropriate heating and mixing and can be introduced in known manner into the display cells.

Liquid crystal compounds according to the invention of the formula (1) are of particular advantage, in particular for base mixtures which are generally suitable for twisted nematic cells which each require a high degree of multiplexibility in order to offer high information densities, for example for input or/and output facilities in portable systems, for example for text editors, teletext equipment, personal computers, memory oscilloscopes and the like.

Hittich, Reinhard, Weber, Georg, Poetsch, Eike, Kelly, Stephen M., Schad, Hans P.

Patent Priority Assignee Title
Patent Priority Assignee Title
3058953,
4035056, Apr 22 1975 The Secretary of State for Defence in Her Britannic Majesty's Government Biphenyl derivative compounds and liquid crystal materials and devices containing such compounds
4108906, Jun 06 1972 GREAT LAKES CHEMICAL CORPORATION, A CORP OF DE Halogenated aryl compounds and processes for preparing the same
4257078, Apr 10 1978 TDK Electronics Co., Ltd. Read device for plane magnetic recording medium
4261651, May 31 1978 The Secretary of State for Defence in Her Britannic Majesty's Government Liquid crystal compounds
4368135, Jul 18 1979 E MERCK PATENT GMBH, A CORP OF GERMANY Anisotropic compounds with negative or positive DC-anisotropy and low optical anisotropy
4400293, Oct 29 1980 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystalline cyclohexylphenyl derivatives
4424371, Sep 23 1982 MERECK PATENT, GMBH FRANKFURTER STRASSE 250, 6100 DARMSTADT A COMPANY OF GERMANY 3-Chloro-4-cyanophenyl 4'-substituted benzoates
4455261, Nov 11 1981 Dainippon Ink and Chemicals, Inc.; Hitachi, Ltd. 4-N-Alkylbenzoyloxy-3'-fluoro-4'-cyanobenzenes
4455443, Sep 10 1981 Dainippon Inc.; Chemicals, Inc. Nematic halogen Compound
4502974, Mar 31 1982 Chisso Corporation High temperature liquid-crystalline ester compounds
4510069, Aug 26 1982 Merck Patent Gesellschaft Mit Beschrankter Haftung Cyclohexane derivatives
4512636, Jun 15 1982 Qinetiq Limited Liquid crystal compounds
4551280, Oct 30 1982 Dainippon Ink and Chemicals, Inc. Nematic liquid crystalline compounds
4556745, Feb 13 1981 Qinetiq Limited Liquid crystal compounds
4564694, Feb 25 1981 Hitachi, Ltd.; Kanto Chemical Co., Inc. Colorless liquid crystalline compounds
4565425, Mar 16 1983 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystals
4583826, Oct 19 1981 Merck Patent Gesellschaft Mit Beschrankter Haftung Phenylethanes
4602851, May 20 1983 Qinetiq Limited Disubstituted ethanes and their use in liquid crystal materials and devices
4606845, May 14 1983 Merck Patent Gesellschaft Mit Beschrankter Haftung Bicyclohexylethanes
4621901, Jul 12 1984 Merck Patent Gesellschaft Mit Beschrankter Haftung Novel liquid crystal mixtures
4630896, Jun 17 1983 Hoffmann-La Roche Inc. Benzonitriles
4637897, Aug 04 1983 Merck Patent Gesellschaft Mit Beschrankter Haftung Nematic compounds
4652089, Nov 02 1983 HOFFMANN-LA ROCHE INC A CORP OF NJ; F HOFFMANN-LA ROCHE & CO , AKTIENGESELLSCHAFT Liquid crystalline compounds and mixtures
4659502, Jan 17 1984 Merck Patent Gesellschaft Mit Beschrankter Haftung Ethane derivatives
4664840, May 28 1979 E MERCK, POSTFACH 4119 D-6100 DARMSTADT, WEST Liquid crystal compounds
4709030, Jul 12 1984 Merck Patent Gesellschaft Mit Beschrankter Haftung Novel liquid crystal mixtures
4724097, May 14 1983 Merck Patent Gesellschaft Mit Beschrankter Haftung Bicyclohexylethanes
4770503, Mar 26 1985 Hoffmann-LaRoche Inc. Liquid crystalline compounds
4797228, Jun 10 1985 Chisso Corporation Cyclohexane derivative and liquid crystal composition containing same
4820443, Feb 06 1987 Chisso Corporation Cyclohexane derivative and liquid crystal composition containing the same
4877547, Feb 26 1986 Merck Patent Gesellschaft Mit Beschrankter Haftung Liquid crystal display element
4917819, Jun 10 1985 Chisso Corporation Cyclohexane derivative and liquid crystal composition containing same
4925590, Mar 10 1988 Merck Patent Gesellschaft Mit Beschrankter Haftung Derivatives of 4-cyano-2,3-difluorophenol
4985583, Aug 26 1982 Merck Patent Gesellschaft mit Beschraenkter Haftung Cyclohexane derivatives
DE2404999,
DE2635099,
DE2635100,
DE2709032,
DE2731214,
DE3317597,
DE3317921A1,
DE3410734,
EP19665,
EP23728,
EP28305,
EP84194,
EP107116,
EP129177,
EP149208,
EP168683,
GB2078727,
GB2121406,
GB2134110,
GB786128,
JP57154158,
JP5738760,
JP5750933,
JP5754137,
JP5759851,
JP58118543,
JP58121266,
JP58126839,
JP5813544,
JP5849355,
JP59157057,
JP5980485,
JP6013731,
JP60224666,
/
Executed onAssignorAssigneeConveyanceFrameReelDoc
Apr 01 1993Merck Patent GmbH(assignment on the face of the patent)
Date Maintenance Fee Events
Jan 03 2001ASPN: Payor Number Assigned.


Date Maintenance Schedule
Sep 05 20034 years fee payment window open
Mar 05 20046 months grace period start (w surcharge)
Sep 05 2004patent expiry (for year 4)
Sep 05 20062 years to revive unintentionally abandoned end. (for year 4)
Sep 05 20078 years fee payment window open
Mar 05 20086 months grace period start (w surcharge)
Sep 05 2008patent expiry (for year 8)
Sep 05 20102 years to revive unintentionally abandoned end. (for year 8)
Sep 05 201112 years fee payment window open
Mar 05 20126 months grace period start (w surcharge)
Sep 05 2012patent expiry (for year 12)
Sep 05 20142 years to revive unintentionally abandoned end. (for year 12)